Showing items 1 - 3 of 3

Your selections:

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

- Spelman, Tim, Eichau, Sara, Grammond, Pierre, Lechner-Scott, Jeanette, Gray, Orla, Amato, Maria Pia, Laureys, Guy, Shaygannejad, Vahid, Hyde, Robert, Wang, Haijue, Bozin, Ivan, Belviso, Nicholas, Alroughani, Raed, Quan, Chao, Zeng, Feng, van der Walt, Anneke, Butzkueven, Helmut, MSBase Study Group,, Ozakbas, Serkan, Khoury, Samia J, Patti, Francesco, Havrdova, Eva Kubala, Boz, Cavit, Terzi, Murat, Kuhle, Jens

DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate

- Maltby, Vicki E., Lea, Rodney A., Ribbons, Karen A., Sanders, Katherine A., Kennedy, Daniel, Min, Myintzu, Scott, Rodney J., Lechner-Scott, Jeannette

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

- Spelman, T., Mekhael, L., Grammond, P., Barnett, M., Lechner-Scott, J., Alroughani, R., Trojano, M., Lugaresi, A., Granella, F., Pucci, E., Vucic, S., Burke, T., Butzkueven, H., Hodgkinson, S., Havrdova, E., Horakova, D., Duquette, P., Izquierdo, G., Grand'Maison, F.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit